Analyst Consensus ?
ConsensusBuy52 ratings
Bullish3771.2%
Neutral1528.8%
Bearish00.0%
FN2 Earnings Intelligence
Stryker Corporation complete analyst coverage
Stryker Corporation (SYK) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$306.13Current
$260Low
$356.36Average
$465High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| BTIG | Buy | Buy | Maintain | Oct 12, 2026 |
| Truist Securities | Hold | Hold | Maintain | Oct 7, 2026 |
| Stifel | Buy | Buy | Maintain | Sep 30, 2026 |
| TD Cowen | Hold | Hold | Maintain | Sep 22, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Sep 18, 2026 |
| Citigroup | Buy | Buy | Maintain | Sep 10, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Sep 9, 2026 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Aug 13, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Aug 3, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 31, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 31, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 31, 2026 |
| BMO Capital | Outperform | Market Perform | Upgrade | Jul 9, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 6, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Jun 5, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 4, 2026 |
| Needham | Buy | Buy | Maintain | May 1, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Apr 9, 2026 |
| UBS | Neutral | Neutral | Maintain | Mar 17, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jan 9, 2026 |
| JMP Securities | Market Perform | Market Perform | Maintain | May 5, 2025 |
| Roth MKM | Buy | Buy | Maintain | May 2, 2025 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Dec 2, 2024 |
| Baird | Outperform | Outperform | Maintain | Oct 30, 2024 |
| B of A Securities | Buy | Neutral | Upgrade | Sep 5, 2023 |
| Argus Research | Buy | Buy | Maintain | May 25, 2023 |
| Jefferies | Buy | Buy | Maintain | May 2, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | May 2, 2023 |
| Loop Capital | Buy | Buy | Maintain | Apr 17, 2023 |
| Edward Jones | Buy | Hold | Upgrade | Jul 28, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jul 22, 2022 |
| SVB Leerink | Outperform | Outperform | Maintain | Jan 28, 2022 |
| Oppenheimer | Perform | Perform | Maintain | Jul 28, 2021 |
| Northland Capital Markets | Outperform | Market Perform | Upgrade | Jul 28, 2021 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 28, 2021 |
| Raymond James | Outperform | Outperform | Maintain | Apr 28, 2021 |
| CFRA | Strong Buy | Strong Buy | Maintain | May 1, 2020 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jan 29, 2020 |
| Piper Jaffray | Overweight | Overweight | Maintain | Jul 26, 2019 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Jul 26, 2019 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Leerink Swann | Outperform | Outperform | Maintain | Jan 31, 2018 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Apr 27, 2016 |
| Sterne Agee | Buy | Neutral | Upgrade | Apr 27, 2016 |
| Brean Capital | Buy | Hold | Upgrade | Jan 27, 2016 |
| Northland Securities | Market Perform | Outperform | Downgrade | Jan 7, 2016 |
| SunTrust Robinson Humphrey | Neutral | Reduce | Upgrade | Apr 14, 2014 |
| Wunderlich Securities | Hold | Buy | Downgrade | Jul 19, 2013 |
| Wunderlich | Hold | Buy | Downgrade | Jul 19, 2013 |
| Standpoint Research | Hold | Buy | Downgrade | Dec 18, 2012 |
| Bank of America | Buy | Buy | Maintain | Dec 12, 2012 |
| PiperJaffray | Neutral | Overweight | Downgrade | Aug 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $306.13. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| BTIG | Ryan Zimmerman | $316 | $279.83 | +3.2% | Oct 12, 2026 |
| Barclays | Analyst unavailable | $375 | $278.5 | +22.5% | Oct 6, 2026 |
| Truist Financial | Analyst unavailable | $310 | $280.22 | +1.3% | Oct 6, 2026 |
| Stifel Nicolaus | Analyst unavailable | $330 | $278.86 | +7.8% | Sep 30, 2026 |
| Canaccord Genuity | Analyst unavailable | $385 | $280.14 | +25.8% | Sep 18, 2026 |
| BMO Capital | Joanne Wuensch | $317 | $277.89 | +3.6% | Sep 9, 2026 |
| Wells Fargo | Larry Biegelsen | $348 | $276.43 | +13.7% | Sep 9, 2026 |
| RBC Capital | Shagun Singh | $420 | $321.08 | +37.2% | Jul 31, 2026 |
| Raymond James | Analyst unavailable | $370 | $322.69 | +20.9% | Jul 31, 2026 |
| BTIG | Ryan Zimmerman | $358 | $322.13 | +16.9% | Jul 31, 2026 |
| Piper Sandler | Analyst unavailable | $390 | $348.37 | +27.4% | Jul 31, 2026 |
| Wolfe Research | Analyst unavailable | $375 | $348.37 | +22.5% | Jul 31, 2026 |
| BTIG | Analyst unavailable | $371 | $329.78 | +21.2% | Jul 13, 2026 |
| Argus Research | Analyst unavailable | $370 | $328.79 | +20.9% | Jul 9, 2026 |
| BMO Capital | Analyst unavailable | $369 | $326.85 | +20.5% | Jul 8, 2026 |
| Evercore ISI | Analyst unavailable | $350 | $319.22 | +14.3% | Jul 6, 2026 |
| Leerink Partners | Mike Kratky | $407 | $301.21 | +33.0% | Jun 5, 2026 |
| Truist Financial | Richard Newitter | $330 | $293.44 | +7.8% | May 4, 2026 |
| Barclays | Matt Miksic | $394 | $294.73 | +28.7% | May 4, 2026 |
| Goldman Sachs | David Roman | $361 | $294.73 | +17.9% | May 1, 2026 |
| Bernstein | Analyst unavailable | $410 | $302.38 | +33.9% | May 1, 2026 |
| Robert W. Baird | Analyst unavailable | $385 | $307.87 | +25.8% | May 1, 2026 |
| Evercore ISI | Analyst unavailable | $355 | $308.17 | +16.0% | May 1, 2026 |
| BTIG | Analyst unavailable | $379 | $315.18 | +23.8% | May 1, 2026 |
| Needham | Analyst unavailable | $418 | $315.18 | +36.5% | May 1, 2026 |
| Deutsche Bank | Analyst unavailable | $315 | $315.18 | +2.9% | May 1, 2026 |
| Jefferies | Matthew Taylor | $465 | $381.89 | +51.9% | Mar 4, 2026 |
| UBS | Analyst unavailable | $400 | $381.83 | +30.7% | Feb 24, 2026 |
| Barclays | Analyst unavailable | $469 | $369.56 | +53.2% | Feb 2, 2026 |
| Needham | Mike Matson | $454 | $365.62 | +48.3% | Jan 30, 2026 |
| Robert W. Baird | Analyst unavailable | $437 | $369.02 | +42.7% | Jan 30, 2026 |
| BTIG | Ryan Zimmerman | $412 | $354.3 | +34.6% | Jan 30, 2026 |
| Bernstein | Lee Hambright | $465 | $367.21 | +51.9% | Jan 9, 2026 |
| Goldman Sachs | Analyst unavailable | $399 | $367.21 | +30.3% | Jan 9, 2026 |
| Raymond James | Analyst unavailable | $418 | $348.79 | +36.5% | Jan 6, 2026 |
| Evercore ISI | Analyst unavailable | $390 | $347.68 | +27.4% | Jan 5, 2026 |
| Truist Financial | Richard Newitter | $400 | $366.38 | +30.7% | Nov 14, 2025 |
| RBC Capital | Shagun Singh | $435 | $365.14 | +42.1% | Nov 14, 2025 |
| Needham | Mike Matson | $448 | $373.42 | +46.3% | Nov 14, 2025 |
| Truist Financial | Analyst unavailable | $392 | $359.36 | +28.1% | Nov 3, 2025 |
| Evercore ISI | Analyst unavailable | $405 | $357.6 | +32.3% | Oct 31, 2025 |
| Truist Financial | Analyst unavailable | $407 | $370.88 | +33.0% | Oct 15, 2025 |
| UBS | Analyst unavailable | $408 | $364.6 | +33.3% | Oct 13, 2025 |
| Evercore ISI | Analyst unavailable | $410 | $366.28 | +33.9% | Oct 7, 2025 |
| Redburn Partners | Analyst unavailable | $420 | $376.8 | +37.2% | Sep 18, 2025 |
| Truist Financial | Analyst unavailable | $415 | $381.49 | +35.6% | Aug 4, 2025 |
| Bernstein | Lee Hambright | $450 | $381.36 | +47.0% | May 5, 2025 |
| BTIG | Ryan Zimmerman | $403 | $353.42 | +31.6% | Apr 14, 2025 |
| Goldman Sachs | Analyst unavailable | $422 | $389.92 | +37.8% | Mar 4, 2025 |
| Argus Research | David Toung | $450 | $391.14 | +47.0% | Feb 3, 2025 |
| Truist Financial | Richard Newitter | $409 | $359.17 | +33.6% | Dec 18, 2024 |
| Morgan Stanley | Patrick Wood | $445 | $390.9 | +45.4% | Dec 2, 2024 |
| Citigroup | Joanne Wuensch | $411 | $363.43 | +34.3% | Oct 31, 2024 |
| Piper Sandler | Matt O'Brien | $420 | $367.95 | +37.2% | Oct 30, 2024 |
| Truist Financial | Richard Newitter | $380 | $365.42 | +24.1% | Oct 30, 2024 |
| Canaccord Genuity | Kyle Rose | $400 | $359.01 | +30.7% | Oct 30, 2024 |
| BTIG | Ryan Zimmerman | $394 | $359.01 | +28.7% | Oct 30, 2024 |
| Truist Financial | Richard Newitter | $370 | $356.45 | +20.9% | Oct 14, 2024 |
| Piper Sandler | Matt O\'Brien | $380 | $365.22 | +24.1% | Sep 10, 2024 |
| BTIG | Ryan Zimmerman | $374 | $358.51 | +22.2% | Aug 28, 2024 |
| Truist Financial | Richard Newitter | $345 | $327 | +12.7% | Aug 1, 2024 |
| BTIG | Ryan Zimmerman | $360 | $330.22 | +17.6% | Jul 31, 2024 |
| Goldman Sachs | David Roman | $372 | $341.14 | +21.5% | May 30, 2024 |
| Argus Research | David Toung | $380 | $330.51 | +24.1% | May 22, 2024 |
| Needham | Mike Matson | $392 | $330.51 | +28.1% | May 22, 2024 |
| BTIG | Ryan Zimmerman | $366 | $342.05 | +19.6% | Apr 15, 2024 |
| Piper Sandler | Matt O'Brien | $280 | $253.81 | -8.5% | Jan 31, 2023 |
| Morgan Stanley | Analyst unavailable | $260 | $254.93 | -15.1% | Jan 6, 2023 |
| BTIG | Ryan Zimmerman | $268 | $239.65 | -12.5% | Dec 21, 2022 |
| Cowen & Co. | Cowen Cowen | $283 | $239.84 | -7.6% | Dec 19, 2022 |
| Barclays | Analyst unavailable | $257 | $238.76 | -16.0% | Dec 2, 2022 |
| Piper Sandler | Matt O’Brien | $260 | $206.93 | -15.1% | Sep 24, 2022 |
| BTIG | Analyst unavailable | $238 | $202.61 | -22.3% | Sep 6, 2022 |
| BTIG | Analyst unavailable | $244 | $192.91 | -20.3% | Jul 18, 2022 |
| Stifel Nicolaus | Analyst unavailable | $245 | $193.26 | -20.0% | Jul 18, 2022 |
| Argus Research | David Toung | $270 | $232.41 | -11.8% | May 23, 2022 |
| Truist Financial | Richard Newitter | $280 | $236.97 | -8.5% | May 3, 2022 |
| Morgan Stanley | Analyst unavailable | $270 | $236.97 | -11.8% | May 2, 2022 |
| Piper Sandler | Matt O’Brien | $290 | $241.26 | -5.3% | Apr 30, 2022 |
| Wells Fargo | Analyst unavailable | $286 | $246.64 | -6.6% | Apr 29, 2022 |
| BTIG | Ryan Zimmerman | $278 | $276.37 | -9.2% | Apr 21, 2022 |
| RBC Capital | Shagun Singh | $272 | $261.7 | -11.1% | Apr 16, 2022 |
| Bernstein | Lee Hambright | $295 | $267.34 | -3.6% | Mar 19, 2022 |
| Bank of America Securities | Travis Steed | $300 | $266.47 | -2.0% | Mar 3, 2022 |
| J.P. Morgan | Robbie Marcus | $265 | $247.76 | -13.4% | Jan 28, 2022 |
| UBS | Matthew Taylor | $267 | $247.76 | -12.8% | Jan 28, 2022 |
| BTIG | Ryan Zimmerman | $273 | $247.76 | -10.8% | Jan 28, 2022 |
| Leerink Partners | Danielle Antalffy | $285 | $247.76 | -6.9% | Jan 28, 2022 |
| Piper Sandler | Matthew O'Brien | $315 | $244.7 | +2.9% | Jan 27, 2022 |
| Deutsche Bank | Pito Chickering | $285 | $254.03 | -6.9% | Jan 21, 2022 |
| Motley Fool | Rick Aristotle Munarriz | $278 | $259.21 | -9.2% | Dec 9, 2021 |
| Loop Capital Markets | Jason Wittes | $305 | $253.11 | -0.4% | Dec 6, 2021 |
| Argus Research | David Toung | $320 | $267.18 | +4.5% | Jul 29, 2021 |
| Canaccord Genuity | Kyle Rose | $290 | $266.68 | -5.3% | Jul 28, 2021 |
| Cowen & Co. | Josh Jennings | $305 | $266.68 | -0.4% | Jul 28, 2021 |
| Credit Suisse | Matt Miksic | $311 | $266.68 | +1.6% | Jul 28, 2021 |
| Oppenheimer | Steven Lichtman | $288 | $266.68 | -5.9% | Jul 28, 2021 |
Track every rating change on SYK the moment it posts. Free to start.
Start freeGet the SYK recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.